Clinical observation of methylpredisolone combinded with methotrexate and dexmethasone via intrathecal injection for neupropsychiatric systemic lupus erythematosus

Wei-fei CHEN,Xiao-xia ZUO,Hui LUO

DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2008.10.010

2008-01-01

Abstract:Objective To investigate the effect and safety of pulse therapy of Methylpredisolone (MP) combinded with Methotrexate (MTX) and Dexmethasone (DXM) via intrathecal injection for Neupropsychiatric Systemic Lupus Erythematosus (NPSLE). Methods Thirty-seven inpatients diagnosed as NPSLE were enrolled in combinded therapy group and received MP 500 mg/d x 3days treatment via intravenous pulse therapy firstly, followed by MP 40～120 mg iv by drip per day, and 2～3 times of MTX (5～10 mg) + DXM (5～10 mg) with intrathecal injection per week. Meanwhile, 33 inpatients with NPSLE were collected randomly as the control group and received the same MP pulse therapy, and CTX (0.5～1.0 g/m2 per body surface area) treatment with iv by drip once per 3～4 weeks. Related clinical parameters and drug adverse reaction were observed in both groups. Results The remission rate and paracmasis in combinded therapy group were better than those in the control (P<0.05), and the mortality was lower in combinded therapy group as contrast to the control. ESR and cerebrospinal fluid (CSF) pressure decreased in both groups, particularly with a significant decrease in combined therapy group (P<0.05). The adverse reaction was less (P<0.05) in combined therapy group also. Conclusion Pulse thrapy of MP combined with MTX shows excellent short-term therapentec effect for NPSLE patients. It ameliorates the activity inderes of pathogenetic condition and reduces the adverse reaction.